Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Well Pharma Medical Research (United States) | Researchclopedia

Back to institutions

Well Pharma Medical Research (United States)

Miami, Floridacompany

5

Works

143

Citations

2

h-index

Top Research Topics

Osteoarthritis Treatment and Mechanisms Inflammatory mediators and NSAID effects Epilepsy research and treatment

Top Researchers

4 works393 citationsh-index: 3

Recent Research

Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

Matthew W. McCarthy,Susanna Naggie,et al.

202210 citations

HER2/EGFR in Cancer Research

Wnt/β-catenin signaling in development and cancer

Tryptophan and brain disorders

Analytical Methods in Pharmaceuticals

Pharmacological Receptor Mechanisms and Effects

Plant-based Medicinal Research

Cancer-related gene regulation

E. Armas Dermatology Consulting Services

5 works303 citationsh-index: 2

Juan Ruiz-Unger Worldwide Clinical Trials (United States)

8 works272 citationsh-index: 5

THU0455 PHARMACOKINETICS (PK) OF A SINGLE INTRA-ARTICULAR (IA) INJECTION OF CNTX-4975 (TRANS-CAPSAICIN) VS TOPICAL 8% CAPSAICIN PATCH

Randall M. Stevens,K.J.T. Guedes,et al.

20190 citations

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

Yusuf Yazıcı,Timothy E. McAlindon,et al.

2017131 citations

SAT0552 Clinical outcomes from a randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, injectable, WNT pathway inhibitor (SM04690) for the treatment of knee osteoarthritis: week 26 interim analysis

Yusuf Yazıcı,Allan Gibofsky,et al.

20171 citations

OP0166 Radiographic outcomes from a randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, injectable, wnt pathway inhibitor (SM04690) in the treatment of osteoarthritis of the knee: week 26 interim analysis

Yusuf Yazıcı,TE McAlindon,et al.

20171 citations